ML

Myla Lai-Goldman

Co-Founder and Chair at GeneCentric Therapeutics, Inc.

South Burlington, Vermont

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Diagnostics
Hardware Diagnostics
Infectious Diseases
Biotechnology
Oncology
Personalized Medicine
Genomics
Lifesciences
Cancer
Commercialization
Immunology
Molecular Biology
Clinical Development
Drug Development
Technology Transfer
Drug Discovery
Pharmaceutical Industry
Biopharmaceuticals
Healthcare
Genetics

Education

Investments

Biocogniv

Seed

Total Funding: $6M

Work Experience

GeneCentric Therapeutics, Inc.

2021

  • Co-Founder and Chair

    2021

Hatteras Venture Partners

2011

  • Venture Partner

    2011

Personalized Science, LLC

2009

  • Managing Partner

    2009

GeneCentric Therapeutics, Inc

2019 - 2021

  • Executive Chair

    2019 - 2021

GeneCentric Diagnostics, Inc.

2011 - 2018

  • Chief Executive Officer

    2011 - 2018

LabCorp

1990 - 2008

  • Executive VP, CMO & CSO

    1990 - 2008